Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.
- DOI
- 10.1016/j.jaad.2017.12.038
- Published
- 2018 Jun
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2017.12.038,
title = {Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.},
author = {Benzaquen M and Borradori L and Berbis P and Cazzaniga S and Valero R and Richard MA and Feldmeyer L},
year = {2018},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2017.12.038},
url = {https://doi.org/10.1016/j.jaad.2017.12.038}
}RIS
TY - JOUR TI - Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland. AU - Benzaquen M AU - Borradori L AU - Berbis P AU - Cazzaniga S AU - Valero R AU - Richard MA AU - Feldmeyer L PY - 2018 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2017.12.038 UR - https://doi.org/10.1016/j.jaad.2017.12.038 ER -
APA
M, B., L, B., P, B., S, C., R, V., MA, R., & L, F. (2018). Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2017.12.038
Source records
- pubmed · retrieved 2026-09-26T11:23:54.913Z